New drug application
Nemluvio Powder and Solvent for solution for injection in Pre-filled Pen/Syringe 30mg
30 April 2026
The summary report for this therapeutic product is available for download
Summary report for Veoza
Active ingredient | Product Registrant | Approval date | Summary report |
|---|---|---|---|
Nemolizumab | Galderma SingaporePrivate Limited | 17 March 2025 |
